Platinum Showcases

The Impact of Protocol Compliance on Central Line Associated Blood Stream Infections (CLABSIs)

Monday, September 17
4:30 PM - 5:00 PM
Location: Room C171-172

Ann is a cancer survivor who underwent multiple surgeries due to a hospital acquired infection. Learn how protocol compliance can impact patient outcomes and therefore total costs. Human factor engineered products can help improve protocol compliance and reduce the total cost of clinical care delivery.

If you are interested in receiving more information about this presentation please contact:
Ann Dine at Ann.Dine@owens-minor.com.

Learning Objectives:


Supported By: 

Ann Dine

Product Manager
Medical Action Industries, an Owens & Minor company

Since joining Medical Action Industries, Inc. (Part of the Owens & Minor Family) in 2015, Ann Dine has worked across product development and marketing. As a cancer survivor who underwent multiple surgeries due to a surgical site infection, Ann is particularly interested in improving hospital protocol adherence to reduce HAIs.

Among her professional accomplishments, Ann was the product manager who developed the patent-pending Clear Sequence™ kit which incorporates human factors into the design, making it easier for clinicians to properly follow clinical protocol in high-risk and/or complex procedures.

After growing up on a working farm, Ann attended nursing school and got first-hand experience working in nursing homes. She graduated Purdue University with a Bachelor of Science in Psychology.

Presentation(s):

Send Email for Ann Dine

Gary Rabinovich

Presentation(s):

Send Email for Gary Rabinovich


Assets

The Impact of Protocol Compliance on Central Line Associated Blood Stream Infections (CLABSIs)

Slides

Attendees who have favorited this

Please enter your access key

The asset you are trying to access is locked. Please enter your access key to unlock.

Send Email for The Impact of Protocol Compliance on Central Line Associated Blood Stream Infections (CLABSIs)